Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.
Heartflow is a publicly traded company (HTFL) that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 750,000 patients worldwide.
Heartflow is that rare company where massive commercial success meets deep clinical impact. We already have high-revenue, production-grade AI products backed by 15 years of rigorous research. We are leveraging our deep foundational AI expertise to add serious fuel to our high-growth fire. We are assembling a brand-new, dedicated team to pioneer production-grade Agentic AI systems within healthcare, fundamentally redefining clinical workflows and physician decision-making from the ground up.
Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.
Heartflow is a publicly traded company (HTFL) that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 750,000 patients worldwide.
Are you a highly analytical software engineer passionate about building scalable tools, optimizing cloud compute infrastructure, and maximizing ROI? Do you thrive on writing elegant code to solve complex infrastructure, storage, and FinOps challenges? Join our dynamic Infrastructure Platform team and help us drive a critical initiative to ensure our modernized Kubernetes workflows and large-scale data systems are as cost-effective as they are powerful.
A reasonable estimate of the base salary compensation range is $180,000 to $215,000, bonus, and equity. #LI-IB1 #LI-Hybrid
Join 2,000+ DevOps developers getting weekly alerts for remote and US/EU roles, Kubernetes, AWS, Terraform, filtered for your stack.
Get a dedicated static EU outbound IP for Banks, payments, EHRs, APIs, AI.
Get instant access to exclusive DevOps jobs with €120K+ salaries
Best value for job search
Only €4.13/month - Save 75%